Eaglenos
Latest round
- Series A
Last raised
- May 2023
Total raised
- $21M
Investors
- 4
About Eaglenos
Established in 2018 and based in Nanjing, China, Eaglenos is a medical device company that focuses on developing and manufacturing precision testing and diagnostic products. The company's manufacturing team has 20 years of experience in medical device production management, more than 10 production lines, and several factory construction experiences. It received registration certificates for 11 products in 2021 and obtained ISO13485 system certification. The founder of this company, Dr. Yu Qin, graduated from Auburn University and has more than 20 years of research experience in the field of electrochemical sensors, teaching at the Department of Chemistry of the Renmin University of China and the School of Chemistry and Chemical Engineering of Nanjing University. As of 2023, it has 220 people. The company's main business is the development, production, and sales of precision POCT and health management products. Its self-developed products include a blood glucose and uric acid tester, blood glucose and lactate tester, blood glucose and blood ketone tester, blood gas and biochemistry analyzer, electrolyte analyzer, continuous temperature monitoring patch, finger clip oximeter, and full solid-state high-resolution electrochemical microscope. Its products are used in the field of diabetes mellitus, hyperuricemia, and cardiovascular and cerebrovascular diseases.
Who invested in Eaglenos
4 investors across 1 round
See all investors in Eaglenos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 29, 2023
Amount
$21M
Investors
Questions about Eaglenos
Who invested in Eaglenos?
Eaglenos has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eaglenos raised?
Eaglenos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eaglenos last raise money?
Eaglenos's most recent round on record is a Series A, in May 2023.
What does Eaglenos do?
Established in 2018 and based in Nanjing, China, Eaglenos is a medical device company that focuses on developing and manufacturing precision testing and diagnostic products.
Where is Eaglenos headquartered?
Eaglenos is headquartered in Nanjing, China.
Which VCs invest in companies like Eaglenos?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Eaglenos's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Eaglenos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.